ReWalk Robotics Full Year 2022 Earnings Revenues Beat Expectations, EPS Lags
RWLKDelisted Stock | USD 0.74 0.01 1.33% |
About 62% of Rewalk Robotics' investor base is looking to short. The analysis of current outlook of investing in Rewalk Robotics suggests that many traders are alarmed regarding Rewalk Robotics' prospects. Rewalk Robotics' investing sentiment shows overall attitude of investors towards Rewalk Robotics.
Rewalk |
ReWalk Robotics Full Year 2022 Results Key Financial Results Net loss US19.6m loss widened by 54...
Read at finance.yahoo.com
Rewalk Robotics Fundamental Analysis
We analyze Rewalk Robotics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rewalk Robotics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rewalk Robotics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Rewalk Robotics is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Rewalk Robotics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rewalk Robotics stock to make a market-neutral strategy. Peer analysis of Rewalk Robotics could also be used in its relative valuation, which is a method of valuing Rewalk Robotics by comparing valuation metrics with similar companies.
Peers
Rewalk Robotics Related Equities
TIVC | Tivic Health | 7.30 | ||||
VVOS | Vivos Therapeutics | 6.87 | ||||
SGHT | Sight Sciences | 4.69 | ||||
HSCS | Heart Test | 4.26 | ||||
IINNW | Inspira Technologies | 4.17 | ||||
NPCE | Neuropace | 3.50 | ||||
LNSR | LENSAR | 2.67 | ||||
BRSYF | BrainsWay | 0.00 | ||||
SRDX | SurModics | 0.40 | ||||
TNON | Tenon Medical | 0.54 | ||||
NUWE | Nuwellis | 0.99 | ||||
BBLG | Bone Biologics | 1.90 | ||||
ICCM | Icecure Medical | 2.61 | ||||
SSKN | STRATA Skin | 3.67 | ||||
NAOV | NanoVibronix | 4.89 | ||||
RPID | Rapid Micro | 7.22 | ||||
BJDX | Bluejay Diagnostics | 7.91 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Rewalk Stock
If you are still planning to invest in Rewalk Robotics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rewalk Robotics' history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |